NCT/Study#

NCT04551885 /

FT516-102

A Phase I, Open-Label, Multicenter Study of FT516 in Combination with Monoclonal Antibodies in Subjects with Advanced Solid Tumors

A Phase I, Open-Label, Multicenter Study of FT516 in Combination with Monoclonal Antibodies in Subjects with Advanced Solid Tumors

DISEASE GROUP:
Phase 1
current phase:
Phase I
STUDY STATUS:
Accepting Patients
Location:
Hackensack, NJ
For More information: